Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal rhHNS Extension in Sanfilippo A
NCT01299727Phase 2Terminated
- Sponsor
- Takeda
- Start
- Mar 2011
- Primary completion
- Apr 2019
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of recombinant human heparan-N-sulfatase in Sanfilippo syndrome type A, sponsored by Takeda. Started Mar 2011; status: terminated.
02
Drugs
recombinant human heparan-N-sulfatase
03
Conditions
Sanfilippo syndrome type A
Beyond the preview
Go deeper on NCT01299727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299727.